Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$207K Buy
+4,082
New +$190K ﹤0.01% 1462
2024
Q4
Sell
-6,585
Closed -$421K 1692
2024
Q3
$421K Sell
6,585
-319
-5% -$29.3K 0.01% 999
2024
Q2
$802K Buy
+6,904
New +$874K 0.01% 602
2021
Q4
Sell
-660
Closed -$254K 235
2021
Q3
$254K Buy
+660
New +$243K 0.01% 187

Other funds holding MRNA

Choreo LLC's MRNA Position: Q1 2026 in Review

Choreo LLC opened a new position in Moderna (MRNA) in Q1 2026: 4,082 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1462 among its holdings. This is a return to the name: Choreo LLC previously reported a position in MRNA as recently as Q3 2024.

Choreo LLC first reported a position in MRNA in Q3 2021 and has held it in 4 quarters since. The position peaked at $802K in Q2 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Choreo LLC held 4,082 shares of Moderna worth $207K as of Q1 2026.
  • Moderna was a new Choreo LLC position in Q1 2026.
  • Moderna made up ﹤0.01% of Choreo LLC's portfolio in Q1 2026, its #1462 holding.
  • Choreo LLC first reported a position in Moderna in Q3 2021 and has held it in 4 quarters since.
  • Choreo LLC's Moderna position peaked at $802K in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.